William Blair Investment Management LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 484,420 shares of the healthcare conglomerate’s stock after selling 38,967 shares during the period. William Blair Investment Management LLC owned about 0.05% of UnitedHealth Group worth $177,821,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. Nvwm LLC raised its stake in UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 33 shares during the last quarter. Wellington Altus USA Inc. boosted its stake in UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak acquired a new stake in UnitedHealth Group during the 2nd quarter worth $29,000. Compass Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth $29,000. Finally, Aberdeen Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 0.0%
NYSE UNH opened at $407.62 on Monday. The business’s fifty day simple moving average is $391.36 and its 200-day simple moving average is $365.66. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market cap of $365.23 billion, a PE ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the firm posted $2.59 earnings per share. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on UNH. TD Cowen reissued a “hold” rating and issued a $402.00 price target on shares of UnitedHealth Group in a research note on Thursday, October 15th. Erste Group Bank cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. Raymond James Financial reiterated an “outperform” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Mizuho raised their target price on shares of UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a research note on Thursday, October 22nd. Finally, Wells Fargo & Company lowered their target price on UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a report on Tuesday, October 27th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.
Get Our Latest Stock Report on UNH
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.19% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Read More
- Five stocks we like better than UnitedHealth Group
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
